What is G6PD Deficiency?
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the world. G6PD is the first and rate-limiting enzyme in…
Excellence Indonesia or EXEINS Health Initiative (EHI) was conceived as Socio-Techno Enterprise striving for research and development in health and molecular medicine. EHI aims to be a contract research organization (CRO) that seeks to innovate and nurture the development of medical products and novel therapies with state-of-the-art technology.
As a global standard research organization, we are committed to providing the best service, which we carry out sincerely and responsibly for the satisfaction of all customers
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the world. G6PD is the first and rate-limiting enzyme in…
On 29 July 2025, EHI researchers Illene Nanine and Devin attended the seminar “Guest Lecture Future Scholar Spotlight: Precision Health…
The Faculty of Medicine, Universitas Sumatera Utara (FK USU), in collaboration with the SingHealth Duke-NUS Global Health Institute (SDGHI), hosted…
Copyright © EHI 2022. All rights reserved.